ProSomnus Sleep Technologies announced record revenues for the quarter that ended June 30, 2024, as it formally emerged from reorganization on August 5, 2024. Revenues for the second quarter totaled a record $9.1 million reflecting increasing orders for the Company’s precision intraoral medical devices. These quarterly results reflect a 22% […]
Tag: DENTAL SLEEP MEDICINE
ProSomnus Files Chapter 11 Bankruptcy to Secure Financial Future
ProSomnus, Inc. announced it has initiated a voluntary restructuring process under Chapter 11 of the U.S. Bankruptcy Code to reorganize and strengthen its capital structure going forward, improve financial flexibility and better position the company for long-term success. In connection with this process, the Company has secured the support of […]
Panthera to Present Abstracts and Launch Inaugural “Panthera Sleep Research Grant” at AADSM & SLEEP 2024
Panthera Dental proudly announces that two distinct abstracts were accepted for poster presentations at the AADSM and AASM/SLEEP Annual Meetings. In addition, a funding opportunity through Panthera for investigator-initiated research proposals will be announced. The posters and the “Panthera Sleep Research Grant” reflect Panthera’s dedication to advancing dental sleep medicine […]
Case Study: Integrating OAT in Atrial Fibrillation Management for OSA Patients
As the prevalence of atrial fibrillation (AF) continues to rise, particularly among the aging population, its connection with obstructive sleep apnea (OSA) has become increasingly evident.1 Patients with AF seeking treatment for OSA often present with a complex medical history that includes a number of comorbidities, such as hypertension, acid […]
Swiss Startup Aesyra Raises $3M from Global Investors to Advance Innovations to Tackle Bruxism and OSA
Aesyra, a medical device company pioneering oral appliance technologies to improve sleep, today announced it has raised $3 million in seed financing. The round was led by Supermoon Capital (USA), the world’s first fund focused on sleeptech, and deep tech investor Creadd Ventures (Switzerland) with participation from existing investor Zürcher […]
Transform Dental Sleep 2026
At Transform Dental Sleep 2026, we’ve redefined Dental Sleep Medicine meetings to inspire and empower. Join us for the 3rd annual Transform Dental Sleep Symposium and gain practical strategies to elevate your practice. Unbiased and free from corporate influence, our symposium delivers actionable ideas without the sales pitch. Walk away […]
ProSomnus Raises $10 Million To Fuel Growth and Optimize Operations
ProSomnus, Inc. has announced the completion of a $10 million convertible preferred equity offering led by existing investors Spring Mountain Capital and Cetus Capital, LLC. ProSomnus’s Executive Chair, Chief Executive Officer, and Chief Financial Officer are also participating in the financing. A description of the terms of the offering can […]
SomnoMed Partners with Nexus Dental Systems to Improve Access to Oral Appliance Therapy for OSA Patients
SomnoMed North America announces Nexus Dental Systems (Nexus) as their preferred partner to offer sleep dentistry training and medical billing in the DOD, VA and commercial market segments. “This partnership significantly enhances the objectives of SomnoMed’s Medical Initiative by further enabling and expanding collaborative patient treatment pathways between medical prescribers, […]
Sleep Lab Magazine SLEEP 2023 Conference Edition
Sleep Lab Magazine SLEEP 2023 Conference Edition Cover Article Women and Sleep Kin Yuen, MD Feature Articles Sensor Integration: A Paradigm Shift for Oral Appliances Nathan Costiuc, MSN, APRN, FNP-BC Can’t Stop Dreaming: Taylor’s Narcolepsy Story Taylor Dillon Issue Extras SLEEP 2023 Select Exhibitors The Sleep Technologists Behind the V-Com […]
ProSomnus OSA Medical Devices Receives Patent Allowance Covering Manufacturing Process
ProSomnus, Inc. today announced that the U.S. Patent and Trademark Office (USPTO) has allowed a patent application covering the Company’s proprietary automated manufacturing process for the Company’s precision medical devices; this is the third patent to issue in this family, including already-issued USPN 10,213,280 and USPN 9,808,327. ProSomnus’s intellectual property […]













